tradingkey.logo

Stereotaxis Inc

STXS
2.030USD
+0.050+2.53%
종가 02/06, 16:00ET시세는 15분 지연됩니다
184.90M시가총액
손실P/E TTM

Stereotaxis Inc

2.030
+0.050+2.53%

자세한 내용은 Stereotaxis Inc 회사

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc 정보

종목 코드 STXS
회사 이름Stereotaxis Inc
상장일Aug 12, 2004
CEOFischel (David Leo)
직원 수139
유형Ordinary Share
회계 연도 종료Aug 12
주소710 N Tucker Blvd
도시ST. LOUIS
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호63101
전화13146786100
웹사이트https://www.stereotaxis.com/
종목 코드 STXS
상장일Aug 12, 2004
CEOFischel (David Leo)

Stereotaxis Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
International
13.49M
50.12%
United States
13.43M
49.88%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Fri, Dec 5
마지막 업데이트: Fri, Dec 5
주주
주주 유형
주주
주주
비율
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
기타
51.88%
주주
주주
비율
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
기타
51.88%
주주 유형
주주
비율
Individual Investor
28.86%
Hedge Fund
19.47%
Investment Advisor
17.46%
Investment Advisor/Hedge Fund
9.42%
Corporation
3.30%
Research Firm
0.62%
Bank and Trust
0.07%
Venture Capital
0.04%
Pension Fund
0.01%
기타
20.75%

기관 주식 보유

마지막 업데이트: Mon, Jan 5
마지막 업데이트: Mon, Jan 5
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
184
43.86M
46.99%
-1.92M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
2023Q3
189
52.12M
65.60%
-9.17M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Fischel (Nathan)
13.92M
15.35%
+43.67K
+0.31%
Jul 01, 2025
Dafna Capital Management, LLC
13.68M
14.66%
--
--
Sep 30, 2025
Kiani (Joe E)
8.86M
9.49%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.71M
5.04%
+19.50K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
3.44M
3.69%
+138.48K
+4.19%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.68M
3.94%
+76.90K
+2.13%
Sep 30, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.3%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.85M
3.06%
--
--
Sep 30, 2025
Isaac (Paul J)
2.06M
2.21%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.60M
1.71%
+53.36K
+3.45%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
비율0.03%
Global X Russell 2000 ETF
비율0.01%
Proshares Ultra Russell 2000
비율0.01%
ProShares UltraPro Russell2000
비율0.01%
ProShares Hedge Replication ETF
비율0.01%
iShares Russell 2000 Growth ETF
비율0.01%
iShares Russell 2000 Value ETF
비율0%
iShares Russell 2000 ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI